CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Statement of Cash Flows [Abstract]
Cash and Cash Equivalents, Beginning of Period	$ 2,569	$ 5,569
Operating Activities
Net Earnings	9,203	7,971
Depreciation and Amortization	2,004	2,084
Share-based Compensation Expense	299	249
Deferred Income Taxes	(24)	(1,826)
Gain (Loss) on Disposition of Assets	(370)	(187)
Changes In:
Accounts Receivable	(549)	(450)
Inventories	(601)	(457)
Accounts Payable, Accrued and Other Liabilities	1,441	752
Other Operating Assets and Liabilities	(537)	2,331
Other Noncash Expense	225	201
Total Operating Activities	11,091	10,668
Investing Activities
Capital Expenditures	(2,533)	(2,810)
Proceeds from Asset Sales	22	246
Acquisitions, Net of Cash Acquired	(3,943)	(108)
Purchases of Short-term Investments	(159)	(3,770)
Proceeds from Sales of Short-term Investments	2,535	2,790
Change in Other Investments	(59)	44
Total Investing Activites	(4,137)	(3,608)
Financing Activities
Dividends to Shareholders	(5,561)	(5,449)
Change in Short-term Debt	(1,832)	(1,259)
Additions to Long-term Debt	2,368	5,072
Reductions of Long-term Debt	(1,002)	(1,402)
Treasury Stock Purchases	(3,253)	(5,634)
Impact of Stock Options and Other	2,590	1,158
Total Financing Activities	(6,690)	(7,514)
Effect of Exchange Rate on Cash and Cash Equivalents	(95)	211
Change in Cash and Cash Equivalents	169	(243)
Cash and Cash Equivalents, End of Period	$ 2,738	$ 5,326